CEO: Mihael Hristos Polymeropoulos

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: Vanda Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders to address unmet needs.


Key numbers

Market Capitalization:824056650
Shares Outstanding: 53337000
Float: 51851617.887
Next Earning Date:2020-02-11
TTm EPS: 2.2872
TTm Dividend Rate:
200 days moving average:15.61
50 days moving average: 13.69
One day percent Change: 0.58



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,